Safe use of efalizumab in a psoriasis patient with chronic heart failure due to hypertrophic cardiomyopathy
Cassano, N.; Miracapillo, A.; Buquicchio, R.; Mastrandrea, V.; Vena, G.A.
Giornale Italiano di Dermatologia e Venereologia Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 143(2): 167
2008
ISSN/ISBN: 0392-0488 PMID: 18833044 Document Number: 627070
Document emailed within 1 workday
Related Documents
Fernandez-Obregon, A.C. 2008: Clinical management with efalizumab of a patient with psoriasis and comorbid vitiligo Journal of Drugs in Dermatology: Jdd 7(7): 679-681Riedlbauchová, L.; Janoušek, J.; Veselka, J. 2013: Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy? Journal of Invasive Cardiology 25(6): E128-E132
Crevenna, R.; Quittan, M.; Hülsmann, M.; Wiesinger, Günther.F.; Keilani, M.Y.; Kainberger, F.; Leitha, T.; Fialka-Moser, V.; Pacher, R. 2002: Hypertrophic osteoarthropathy caused by PGE1 in a patient with congestive heart failure during cardiac rehabilitation Wiener Klinische Wochenschrift 114(3): 115-118
Uretsky, B.F. 1988: Diagnostic considerations in the adult patient with cardiomyopathy or congestive heart failure Cardiovascular Clinics 19(1): 35-56
Cardim, N. 1999: Dealing with a special group: hypertrophic cardiomyopathy. Models of diastolic dysfunction in hypertrophic cardiomyopathy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18(Suppl 5): V45-V46
Gottlieb, A.B.; Gordon, K.B.; Lebwohl, M.G.; Caro, I.; Walicke, P.A.; Li, N.; Leonardi, C.L. 2004: Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis Journal of Drugs in Dermatology: Jdd 3(6): 614-624
Câmara, E.J.; Cruz, T.R.; Nassri, J.M.; Rodrigues, L.E. 1986: Muscle magnesium content and cardiac arrhythmias during treatment of congestive heart failure due to chronic chagasic cardiomyopathy Brazilian Journal of Medical and Biological Research 19(1): 49-58
Kuznetsov, G.P.; Duplyakov, D.V.; Popova, I.V.; Avramenko, A.A.; Suslina, E.A.; Tukhbatova, A.A.; Adonina, E.V. 2015: Hypertrophic Cardiomyopathy in a Patient with Dextrocardia Kardiologiia 55(1): 92-95
Boewer, V.; Schröder, G.; Waigand, J.; Lembcke, J. 1984: Hypertrophic cardiomyopathy with midventricular and subvalvular obstruction in both heart ventricles Zeitschrift für Kardiologie 73(8): 525-529
Fukuhara, C.; Sakamoto, K.; Okon, S.; Hokari, H.; Kaizu, S. 1980: Nursing of a hemodialysis (chronic kidney failure) patient with congenital heart defect; a study of a case undergoing open heart surgery Nursing Technique 26(9): 1250-1256
Ancion, A.; Nellessen, E.; Lancelloti, P.; Piérard, L. 2011: How i explore...a patient with chronic heart failure Revue Medicale de Liege 66(7-8): 447-451
Wiegand, V.; Neuhaus, K.L.; Kreuzer, H. 1982: Postoperative left ventricular dilatation in a patient with hypertrophic obstructive cardiomyopathy Zeitschrift für Kardiologie 71(5): 323-325
Sheng, H.-z.; Shan, Q.-j.; Wu, X.; Cao, K.-j. 2008: Cardiac troponin i gene mutation (Asp127Tyr) in a Chinese patient with hypertrophic cardiomyopathy Zhonghua Xin Xue Guan Bing Za Zhi 36(12): 1063-1065
Poliakov, V.P.; Goriachev, V.V.; Val'kov, V.V.; Kolesnik, I.N. 1997: Creation of additional left ventricular tract in female patient with hypertrophic cardiomyopathy Khirurgiia 1: 63-64
Tanabe, T. 1998: Impaired heart rate variability in patients with symptomatic NYHA class II-IIi hypertrophic cardiomyopathy Rinsho Byori. Japanese Journal of Clinical Pathology 46(10): 1030-1036
George, D.; Rosen, T. 2009: Treatment of inverse psoriasis with efalizumab Journal of Drugs in Dermatology: Jdd 8(1): 74-76
Golda, N.; Benham, S.M.; Koo, J. 2006: Rebound of psoriasis during treatment with efalizumab Journal of Drugs in Dermatology: Jdd 5(1): 63-65
Gibelin, P.; Aumont, M.C.; Aupetit, J.F.; Bareiss, P.; Bouhour, J.B.; Desnos, M.; Dubourg, O.; Hagège, A.; Jondeau, G.; Komajda, M. 1999: Evaluation of a specific French scale of activity in chronic heart failure. A national multicenter study. Group for Cardiac Insufficiency and Cardiomyopathy of the French Society of Cardiology Archives des Maladies du Coeur et des Vaisseaux 92(9): 1175-1180
Ślusarczyk, A.; Piechocki, K.; Symonides, B. 2019: Dyspnoe, cough and fever in 80-year old patient with chronic heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 47(281): 187-189
Okuyama, K.; Kashimoto, S.; Iwashita, H.; Kume, M.; Kumazawa, T. 1993: Anesthetic management of a patient with hypertrophic obstructive cardiomyopathy under epidural anesthesia with high dose fentanyl Masui. Japanese Journal of Anesthesiology 42(9): 1363-1366